Yang Chunyan, He Qiying, Huang Liuyang, Tian Hao, Luo Qin, Xu Guixing, Sun Mingsheng, Yang Sha, Liang Fanrong, Litao Pan
Department of Acupuncture and Massage, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China,
Department of Respiratory Medicine, Mianyang Hospital of Traditional Chinese Medicine Affiliated to Chengdu University of Traditional Chinese Medicine, Mianyang, China.
Complement Med Res. 2025;32(1):67-83. doi: 10.1159/000541020. Epub 2025 Jan 27.
Traditional Chinese Medicine (TCM) therapies have shown great improvement in chronic obstructive pulmonary disease (COPD) patients, yet no bibliometric analysis on TCM therapies for COPD exists.
A comprehensive literature search was conducted on TCM therapies for COPD within the past decade, utilizing the Web of Science (WOS) Core Collection and China National Knowledge Infrastructure (CNKI) databases. To analyze collaborative patterns among countries/regions, institutions, and authors, as well as identify influential references and emerging research trends, CiteSpace and VOSviewer software were employed. The dataset comprised 625 articles from WOS and 5,641 from CNKI, revealing a consistent growth in COPD-related TCM research over the past 10 years. China emerged as the leading contributor, with a predominant focus on TCM Universities. The American Journal of Respiratory and Critical Care Medicine was the most cited journal, while Medicine published the highest number of articles. Li JS was the most prolific author, and Barnes PJ was the most frequently cited researcher. Key studies by Leung RWM [Eur Respir J. 2013;41(5):1051-7], Li SY [BMC Complement Altern Med. 2012;12:197], and Polkey MI [Chest. 2018;153(5):1116-24] garnered significant attention. Keyword analysis highlighted the prominence of Tai Chi, Chinese herbal medicine, acupoint sticking, acupuncture, lung function, quality of life, and inflammation as core research themes.
Research on TCM therapies for COPD has gained growing attention over the past decade. Among the most commonly studied TCM interventions are Tai Chi, Chinese herbal medicine, acupoint sticking, and acupuncture. Lung function, quality of life, and inflammation have emerged as key areas of investigation and are likely to remain focal points for future research endeavors.
中医治疗已显示出在慢性阻塞性肺疾病(COPD)患者中取得了显著疗效,但尚未有针对COPD中医治疗的文献计量分析。
利用科学网(WOS)核心合集和中国知网(CNKI)数据库,对过去十年内COPD的中医治疗进行了全面的文献检索。为分析国家/地区、机构和作者之间的合作模式,以及识别有影响力的参考文献和新兴研究趋势,使用了CiteSpace和VOSviewer软件。数据集包括来自WOS的625篇文章和来自CNKI的5641篇文章,显示过去10年中与COPD相关的中医研究持续增长。中国是主要贡献者,主要集中于中医大学。《美国呼吸与危重症医学杂志》是被引用最多的期刊,而《医学》发表的文章数量最多。李建生是发文量最多的作者,而巴恩斯·PJ是被引用次数最多的研究人员。梁伟明[《欧洲呼吸杂志》。2013年;41(5):1051 - 1057]、李时悦[《BMC补充与替代医学》。2012年;12:197]和波尔基·MI[《胸部》。2018年;153(5):1116 - 1124]的关键研究受到了广泛关注。关键词分析突出了太极拳、中药、穴位贴敷、针灸、肺功能、生活质量和炎症作为核心研究主题的突出地位。
在过去十年中,COPD的中医治疗研究越来越受到关注。最常研究的中医干预措施包括太极拳、中药、穴位贴敷和针灸。肺功能、生活质量和炎症已成为关键的研究领域,并且可能仍然是未来研究工作的重点。